CoChat

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks

Open access
Salvan, Piergiorgio, Fonseca, Madalena, Winkler, Anderson M., Beauchamp, Antoine, Lerch, Jason P., Johansen-Berg, Heidi · 2023 · Nature Neuroscience

Published version of a preprint

Abstract

Although we understand how serotonin receptors function at the single-cell level, what role different serotonin receptors play in regulating brain-wide activity and, in turn, human behavior, remains unknown. Here, we developed transcriptomic–neuroimaging mapping to characterize brain-wide functional signatures associated with specific serotonin receptors: serotonin receptor networks (SRNs). Probing SRNs with optogenetics–functional magnetic resonance imaging (MRI) and pharmacology in mice, we show that activation of dorsal raphe serotonin neurons differentially modulates the amplitude and functional connectivity of different SRNs, showing that receptors’ spatial distributions can confer specificity not only at the local, but also at the brain-wide, network level. In humans, using resting-state functional MRI, SRNs replicate established divisions of serotonin effects on impulsivity and negative biases. These results provide compelling evidence that heterogeneous brain-wide distributions of different serotonin receptor types may underpin behaviorally distinct modes of serotonin regulation. This suggests that serotonin neurons may regulate multiple aspects of human behavior via modulation of large-scale receptor networks.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41593-022-01213-3

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Mapping functional signatures of brain-wide SRNs. Gene expression brain maps of serotonin receptor genes are combined with fMRI (both mouse and human) via FSL DR to map temporal and spatial fMRI signatures of different serotonin receptor types. a, DR-stage 1: regresses the spatial maps of serotonin receptor genes into each subject’s four-dimensional (4D) fMRI dataset. This gives a subject-specific time-course quantifying network amplitude changes for each SRN. DR-stage 1 can be used to address questions such as: What are the SRN amplitude changes in response to optogenetic stimulation? b, DR-stage 2: regresses subject-specific time-courses into the same 4D fMRI dataset. This provides a subject-specific spatial map quantifying functional connectivity for each SRN. DR-stage 2 can be used to address questions such as: What are the SRN brain correlates associated with individual differences in a depression scale? Sub, subject.
Fig. 1 Mapping functional signatures of brain-wide SRNs. Gene expression brain maps of serotonin receptor genes are combined with fMRI (both mouse and human) via FSL DR to map temporal and spatial fMRI signatures of different serotonin receptor types. a, DR-stage 1: regresses the spatial maps of serotonin receptor genes into each subject’s four-dimensional (4D) fMRI dataset. This gives a subject-specific time-course quantifying network amplitude changes for each SRN. DR-stage 1 can be used to address questions such as: What are the SRN amplitude changes in response to optogenetic stimulation? b, DR-stage 2: regresses subject-specific time-courses into the same 4D fMRI dataset. This provides a subject-specific spatial map quantifying functional connectivity for each SRN. DR-stage 2 can be used to address questions such as: What are the SRN brain correlates associated with individual differences in a depression scale? Sub, subject.CC BY · PubMed Central
Fig. 2 Activity of DRN serotonin neurons modulates SRNs. a, Mice were genetically manipulated to express ChR2 in DRN serotonin neurons before ofMRI experiments29. b, Transcriptomic maps of serotonin receptor genes from the Allen Brain Institute. The combination of serotonin receptor maps and ofMRI via FSL DR allowed us to characterize SRNs. c, SRN time-courses of amplitude changes (DR-stage 1) during ofMRI. (Δ, changes from baseline activity; see Extended Data Fig. 2a). Top row shows SRN amplitude changes for control animals; bottom row for ChR2 animals. Each color represents an SRN; SRN colors are matched with the other panels. d, Time-locked ofMRI amplitude changes of SRNs (DR-stage 1) in control animals (left) and in ChR2 animals (right). Blue bar underneath represents when optogenetic stimulation was on. e, Results from permutation analysis of linear models testing differences between control and ChR2 animals on SRN time-locked responses. Statistical significance was assessed with 1,000 block-aware permutations, with FWE-corr for multiple comparisons across time, SRNs and two tails. Showing −log10 FWE-corr P, corrected across time, SRNs and two tails. Dashed lines demarcate statistical thresholds. Together, panels d and e show a heterogeneity of SRN amplitude changes in response to optogenetic activation of DRN serotonin neurons. f, Results from permutation analysis of linear models testing differences between control and ChR2 groups on SRN functional connectivity maps (DR-stage 2). Statistical significance was assessed with 1,000 block-aware permutations, with FWE-corr for multiple comparisons across brain regions, SRNs and two tails. Showing −log10 FWE-corr P, corrected across brain regions, SRNs and two tails. Cold colors represent decreased functional connectivity in the ChR2 group compared with the control group; hot colors represent increased functional connectivity. The results of this figure demonstrate that the spatial distribution of different serotonin receptor types confers functional specificity at the brain-wide level. CBV, erebral blood volume; TR, repetition time; vols, volumes.
Fig. 2 Activity of DRN serotonin neurons modulates SRNs. a, Mice were genetically manipulated to express ChR2 in DRN serotonin neurons before ofMRI experiments29. b, Transcriptomic maps of serotonin receptor genes from the Allen Brain Institute. The combination of serotonin receptor maps and ofMRI via FSL DR allowed us to characterize SRNs. c, SRN time-courses of amplitude changes (DR-stage 1) during ofMRI. (Δ, changes from baseline activity; see Extended Data Fig. 2a). Top row shows SRN amplitude changes for control animals; bottom row for ChR2 animals. Each color represents an SRN; SRN colors are matched with the other panels. d, Time-locked ofMRI amplitude changes of SRNs (DR-stage 1) in control animals (left) and in ChR2 animals (right). Blue bar underneath represents when optogenetic stimulation was on. e, Results from permutation analysis of linear models testing differences between control and ChR2 animals on SRN time-locked responses. Statistical significance was assessed with 1,000 block-aware permutations, with FWE-corr for multiple comparisons across time, SRNs and two tails. Showing −log10 FWE-corr P, corrected across time, SRNs and two tails. Dashed lines demarcate statistical thresholds. Together, panels d and e show a heterogeneity of SRN amplitude changes in response to optogenetic activation of DRN serotonin neurons. f, Results from permutation analysis of linear models testing differences between control and ChR2 groups on SRN functional connectivity maps (DR-stage 2). Statistical significance was assessed with 1,000 block-aware permutations, with FWE-corr for multiple comparisons across brain regions, SRNs and two tails. Showing −log10 FWE-corr P, corrected across brain regions, SRNs and two tails. Cold colors represent decreased functional connectivity in the ChR2 group compared with the control group; hot colors represent increased functional connectivity. The results of this figure demonstrate that the spatial distribution of different serotonin receptor types confers functional specificity at the brain-wide level. CBV, erebral blood volume; TR, repetition time; vols, volumes.CC BY · PubMed Central
Fig. 3 Fluoxetine manipulation alters neuromodulation in predicted SRNs. a, ChR2 animals were treated with one pharmacologically significant dose of fluoxetine and then underwent ofMRI. b, Time-locked ofMRI amplitude changes of SRNs in ChR2 animals (left) and in ChR2 animals treated with fluoxetine (right). Each color represents an SRN. c, Results from permutation analysis of linear models testing for group differences in Htr1a, Htr1b and Htr4 SRN time-locked amplitude changes calculated via DR-stage 1, between the ChR2 group and the ChR2 group treated with fluoxetine. Statistical significance was assessed with 1,000 block-aware permutations (whilst allowing permutations only within-subject), with FWE-corr for multiple comparisons across time, SRNs and two tails. Showing −log10 FWE-corr P, corrected across time and two tails. Dashed lines demarcate statistical thresholds. These results show that known pharmacological effects on serotonin receptor types can be detected with our approach, hence providing an important validation, and that the spatial distribution of different serotonin receptor types confers functional specificity when selectively manipulating serotonin availability in synaptic terminals.
Fig. 3 Fluoxetine manipulation alters neuromodulation in predicted SRNs. a, ChR2 animals were treated with one pharmacologically significant dose of fluoxetine and then underwent ofMRI. b, Time-locked ofMRI amplitude changes of SRNs in ChR2 animals (left) and in ChR2 animals treated with fluoxetine (right). Each color represents an SRN. c, Results from permutation analysis of linear models testing for group differences in Htr1a, Htr1b and Htr4 SRN time-locked amplitude changes calculated via DR-stage 1, between the ChR2 group and the ChR2 group treated with fluoxetine. Statistical significance was assessed with 1,000 block-aware permutations (whilst allowing permutations only within-subject), with FWE-corr for multiple comparisons across time, SRNs and two tails. Showing −log10 FWE-corr P, corrected across time and two tails. Dashed lines demarcate statistical thresholds. These results show that known pharmacological effects on serotonin receptor types can be detected with our approach, hence providing an important validation, and that the spatial distribution of different serotonin receptor types confers functional specificity when selectively manipulating serotonin availability in synaptic terminals.CC BY · PubMed Central
Fig. 4 Human mental processes are organized into independent modes of SRN modulation. a, FSL DR approach to derive SRNs in the HCP dataset. b, Individual differences in SRNs were tested for covariation with behaviors via CCA. Permutation inference CCA characterized two statistically significant orthogonal modes of population variation. Each mode captures a relationship between SRN functional connectivity measures (‘imaging cross-loadings’) and behavioral measures (‘behavioral cross-loadings’). Modes 1 and 2 are color-coded in blue and red, respectively, throughout the main figure and the related figure (Extended Data Fig. 4). c, For each mode, imaging cross-loadings are represented as a set of brain regions showing a specific fingerprint of SRN involvement (radial plot, where each axis represents a receptor type). (For un-thresholded imaging cross-loadings, see Extended Data Fig. 4a–c.) d, Scatter plots of significant CCA modes: top: CCA mode 1, r = 0.42; FWE-corr P = 0.0008; bottom: CCA mode 2, r = 0.39; FWE-corr P = 0.0253. Statistical significance assessed via 10,000 block-aware permutations and FWE-corr for multiple comparisons. The scatter plots illustrate the relationship between SRNs and behavior. e, For each mode, behavioral cross-loadings are represented as axial plots illustrating fingerprints of cognitive (left) and affective (right) variables, where each axis represents a behavior score (see Extended Data Fig. 4d for fingerprints on the full set of behavioral variables). f, For each mode, subjects were ranked according to their CCA subject score (which captures how well individuals are represented by the mode phenotype) and divided into ‘high scoring’ and ‘low scoring’ groups. Behavioral scores were then calculated for these two groups separately, for measures of delay discounting, reward and punishment, psychiatric scores (according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)) and affect, to test whether the modes of variation identified by the CCA captured relevant differences in behavior in these domains. On each box, the central mark indicates the median, and the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. Each data point represents an individual (n = 812 individuals). *Significant difference between high- versus low-scoring group (one-way analysis of variance; Bonferroni corrected across two CCA modes and multiple variables within the domain of interest). The results in panel f show that while mode 1 primarily captures variance in delay discounting (P < 10−4), antisocial problems (P < 10−4) and anger/aggression (P < 10−4), mode 2 captures variation in reward (P < 10−4) and punishment (P = 0.0071), depression (P < 10−4) and panic/sadness (P < 10−4). Both modes showed a significant effect on life satisfaction (both, P < 10−4). FC, functional connectivity; T-stat, T-statistic.
Fig. 4 Human mental processes are organized into independent modes of SRN modulation. a, FSL DR approach to derive SRNs in the HCP dataset. b, Individual differences in SRNs were tested for covariation with behaviors via CCA. Permutation inference CCA characterized two statistically significant orthogonal modes of population variation. Each mode captures a relationship between SRN functional connectivity measures (‘imaging cross-loadings’) and behavioral measures (‘behavioral cross-loadings’). Modes 1 and 2 are color-coded in blue and red, respectively, throughout the main figure and the related figure (Extended Data Fig. 4). c, For each mode, imaging cross-loadings are represented as a set of brain regions showing a specific fingerprint of SRN involvement (radial plot, where each axis represents a receptor type). (For un-thresholded imaging cross-loadings, see Extended Data Fig. 4a–c.) d, Scatter plots of significant CCA modes: top: CCA mode 1, r = 0.42; FWE-corr P = 0.0008; bottom: CCA mode 2, r = 0.39; FWE-corr P = 0.0253. Statistical significance assessed via 10,000 block-aware permutations and FWE-corr for multiple comparisons. The scatter plots illustrate the relationship between SRNs and behavior. e, For each mode, behavioral cross-loadings are represented as axial plots illustrating fingerprints of cognitive (left) and affective (right) variables, where each axis represents a behavior score (see Extended Data Fig. 4d for fingerprints on the full set of behavioral variables). f, For each mode, subjects were ranked according to their CCA subject score (which captures how well individuals are represented by the mode phenotype) and divided into ‘high scoring’ and ‘low scoring’ groups. Behavioral scores were then calculated for these two groups separately, for measures of delay discounting, reward and punishment, psychiatric scores (according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)) and affect, to test whether the modes of variation identified by the CCA captured relevant differences in behavior in these domains. On each box, the central mark indicates the median, and the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. Each data point represents an individual (n = 812 individuals). *Significant difference between high- versus low-scoring group (one-way analysis of variance; Bonferroni corrected across two CCA modes and multiple variables within the domain of interest). The results in panel f show that while mode 1 primarily captures variance in delay discounting (P < 10−4), antisocial problems (P < 10−4) and anger/aggression (P < 10−4), mode 2 captures variation in reward (P < 10−4) and punishment (P = 0.0071), depression (P < 10−4) and panic/sadness (P < 10−4). Both modes showed a significant effect on life satisfaction (both, P < 10−4). FC, functional connectivity; T-stat, T-statistic.CC BY · PubMed Central
Extended Data Fig. 1 Spatial correspondence between gene expression maps, SRNs, and PET maps. Related to Fig. 1. a) Showing human brain maps (rank-based inverse normalised) of serotonin receptor genes publicly available from the Allen Brain Institute. b) Showing group-level maps (T-stats) of human brain SRNs functional connectivity (DR-stage 2) estimated by combining transcriptomic maps (displayed in panel a) with resting state fMRI data from the Human Connectome Project using FSL DR as exemplified in Fig. 1. c) Publicly available serotonin receptor density maps previously characterised using PET. (Note, only maps for receptors 5-HT1A, 5-HT2A, and 5-HT4, were available. Here maps are Z-scored for display purposes). d) Spatial PET—HTR correspondence between maps of serotonin receptor density previously characterised using PET (displayed in panel c) and human gene expression maps of serotonin receptors (displayed in panel a). Spatial similarity was calculated using Pearson’s correlation across atlas brain regions. Red squares highlight diagonal elements of the correlation matrix. e) Boxplot showing difference in PET—SRN correspondence between diagonal and off diagonal elements of panel d). f) Spatial PET—SRN correspondence between maps of serotonin receptor density previously characterised using PET (displayed in panel c) and human SRN functional connectivity maps (displayed in panel b). Spatial similarity was calculated using Pearson’s correlation across atlas brain regions. Red squares highlight diagonal elements of the correlation matrix. g) Boxplot showing difference in PET—SRN correspondence between diagonal and off diagonal elements of panel d). In e) and g), on each box, the central mark indicates the median, and the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points not considered outliers. Each data point is plotted individually (n = 9 maps). Together panels e) and g) show greater PET—HTR and PET—SRN spatial correspondence for the same serotonin receptors (diagonal elements) compared with the spatial correspondence between different serotonin receptors (off diagonal elements). FC: functional connectivity.
Extended Data Fig. 1 Spatial correspondence between gene expression maps, SRNs, and PET maps. Related to Fig. 1. a) Showing human brain maps (rank-based inverse normalised) of serotonin receptor genes publicly available from the Allen Brain Institute. b) Showing group-level maps (T-stats) of human brain SRNs functional connectivity (DR-stage 2) estimated by combining transcriptomic maps (displayed in panel a) with resting state fMRI data from the Human Connectome Project using FSL DR as exemplified in Fig. 1. c) Publicly available serotonin receptor density maps previously characterised using PET. (Note, only maps for receptors 5-HT1A, 5-HT2A, and 5-HT4, were available. Here maps are Z-scored for display purposes). d) Spatial PET—HTR correspondence between maps of serotonin receptor density previously characterised using PET (displayed in panel c) and human gene expression maps of serotonin receptors (displayed in panel a). Spatial similarity was calculated using Pearson’s correlation across atlas brain regions. Red squares highlight diagonal elements of the correlation matrix. e) Boxplot showing difference in PET—SRN correspondence between diagonal and off diagonal elements of panel d). f) Spatial PET—SRN correspondence between maps of serotonin receptor density previously characterised using PET (displayed in panel c) and human SRN functional connectivity maps (displayed in panel b). Spatial similarity was calculated using Pearson’s correlation across atlas brain regions. Red squares highlight diagonal elements of the correlation matrix. g) Boxplot showing difference in PET—SRN correspondence between diagonal and off diagonal elements of panel d). In e) and g), on each box, the central mark indicates the median, and the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points not considered outliers. Each data point is plotted individually (n = 9 maps). Together panels e) and g) show greater PET—HTR and PET—SRN spatial correspondence for the same serotonin receptors (diagonal elements) compared with the spatial correspondence between different serotonin receptors (off diagonal elements). FC: functional connectivity.CC BY · PubMed Central
Extended Data Fig. 2 SRNs fluctuations during DRN ofMRI and specificity. Related to Fig. 2. a) Left: Showing SRN fluctuations in absolute (abs) amplitude in response to DRN ofMRI. Yellow area indicates the average SRN absolute (abs) amplitude activity (DR-stage 1 SRN amplitude fluctuations) during the first 40 timepoints. This average activity was subtracted from the remaining timepoints in order to take into account baseline. Right: Showing SRN delta (Δ) amplitude obtained from the process depicted in the left. b) Spatial similarity between all receptor maps: serotonin, acetylcholine, dopamine, and noradrenaline, demonstrating that there is low to modest correlation between most spatial maps as expected, as different receptor maps have distinct though overlapping spatial distributions. Spatial similarity was calculated at the voxel-wise whole-brain level. c) Time-locked ofMRI amplitude changes in SRNs calculated in ChR2 animals (left) via DR stage-1 (as also shown in main figures) and (right) via residualised DR stage-1. Blue bar underneath represents when optogenetic stimulation was on. d) Results from permutation analysis of linear models on residualised DR stage-1 SRN time-locked responses between control and ChR2 animals. Statistical significance was assessed with 1,000 block-aware permutations with FWE-corr for multiple comparisons. Showing -log10 FWE-corr p-values, corrected across time, SRNs, and two tails. Dashed lines demarcate statistical thresholds. e) Time-locked ofMRI amplitude changes in other receptor networks (Nets) calculated in ChR2 animals via residualised DR stage-1. f) Spearman’s partial correlation between multiple neuromodulatory receptor maps and DRN ofMRI activity as previously implemented by Zerbi et al. (see Methods). Two-tailed significance was assessed with permutation testing and partial correlations were deemed significant at FWE-corr P < 0.025. The * symbol above bars indicates a statistically significant FWE-corr p-value. Red bars indicate serotonin receptors. This analysis shows that serotonin receptors have the highest partial correlation values with DRN ofMRI changes.
Extended Data Fig. 2 SRNs fluctuations during DRN ofMRI and specificity. Related to Fig. 2. a) Left: Showing SRN fluctuations in absolute (abs) amplitude in response to DRN ofMRI. Yellow area indicates the average SRN absolute (abs) amplitude activity (DR-stage 1 SRN amplitude fluctuations) during the first 40 timepoints. This average activity was subtracted from the remaining timepoints in order to take into account baseline. Right: Showing SRN delta (Δ) amplitude obtained from the process depicted in the left. b) Spatial similarity between all receptor maps: serotonin, acetylcholine, dopamine, and noradrenaline, demonstrating that there is low to modest correlation between most spatial maps as expected, as different receptor maps have distinct though overlapping spatial distributions. Spatial similarity was calculated at the voxel-wise whole-brain level. c) Time-locked ofMRI amplitude changes in SRNs calculated in ChR2 animals (left) via DR stage-1 (as also shown in main figures) and (right) via residualised DR stage-1. Blue bar underneath represents when optogenetic stimulation was on. d) Results from permutation analysis of linear models on residualised DR stage-1 SRN time-locked responses between control and ChR2 animals. Statistical significance was assessed with 1,000 block-aware permutations with FWE-corr for multiple comparisons. Showing -log10 FWE-corr p-values, corrected across time, SRNs, and two tails. Dashed lines demarcate statistical thresholds. e) Time-locked ofMRI amplitude changes in other receptor networks (Nets) calculated in ChR2 animals via residualised DR stage-1. f) Spearman’s partial correlation between multiple neuromodulatory receptor maps and DRN ofMRI activity as previously implemented by Zerbi et al. (see Methods). Two-tailed significance was assessed with permutation testing and partial correlations were deemed significant at FWE-corr P < 0.025. The * symbol above bars indicates a statistically significant FWE-corr p-value. Red bars indicate serotonin receptors. This analysis shows that serotonin receptors have the highest partial correlation values with DRN ofMRI changes.CC BY · PubMed Central
Extended Data Fig. 3 Cross-receptors relationship between Htr1a and Htr4 SRNs. Related to Fig. 3. a) Results from permutation analysis of linear models for group differences between the ChR2 group treated with fluoxetine and the control group in SRN time-locked amplitude changes. Statistical significance was assessed with 1,000 block-aware permutations (whilst allowing permutations only within-subject), with FWE-corr for multiple comparisons. Showing -log10 FWE-corr p-values, corrected across time and two tails. Dashed lines demark statistical thresholds. b) Showing negative correlations between Htr1a and Htr4 SRN activity. Correlation assessed via one-tail Spearman’s correlation. Left: scatter plot relating fluoxetine-induced changes in Htr1a and Htr4 SRN amplitude during ofMRI experiments. Right: scatter plot relating fluoxetine-induced peak activity in Htr1a and Htr4 SRN amplitude across subjects. For both left and right scatter plots, fluoxetine-induced changes are fluoxetine + ChR2 minus ChR2 only ofMRI amplitude changes.
Extended Data Fig. 3 Cross-receptors relationship between Htr1a and Htr4 SRNs. Related to Fig. 3. a) Results from permutation analysis of linear models for group differences between the ChR2 group treated with fluoxetine and the control group in SRN time-locked amplitude changes. Statistical significance was assessed with 1,000 block-aware permutations (whilst allowing permutations only within-subject), with FWE-corr for multiple comparisons. Showing -log10 FWE-corr p-values, corrected across time and two tails. Dashed lines demark statistical thresholds. b) Showing negative correlations between Htr1a and Htr4 SRN activity. Correlation assessed via one-tail Spearman’s correlation. Left: scatter plot relating fluoxetine-induced changes in Htr1a and Htr4 SRN amplitude during ofMRI experiments. Right: scatter plot relating fluoxetine-induced peak activity in Htr1a and Htr4 SRN amplitude across subjects. For both left and right scatter plots, fluoxetine-induced changes are fluoxetine + ChR2 minus ChR2 only ofMRI amplitude changes.CC BY · PubMed Central
Extended Data Fig. 4 Full set of imaging and behavioural CCA cross-loadings. Related to Fig. 4. a) For each CCA mode, showing non-thresholded brain maps of imaging cross-loadings. As the CCA was carried out on ROI-based SRN functional connectivity values, maps are displayed preserving this level of resolution. To ease visualisation and interpretation, separately for each mode, brain maps of imaging cross-loadings (panel a; brain regions–by–SRNs) were fed to a PCA (extracting only one single component a max variance). This resulted in b) a set of PCA coefficients (SRN fingerprint; also shown in Fig. 4c) and in c) PCA scores (brain map; also shown thresholded in Fig. 4e). d) For each CCA mode, showing the full set of behavioural cross-loadings.
Extended Data Fig. 4 Full set of imaging and behavioural CCA cross-loadings. Related to Fig. 4. a) For each CCA mode, showing non-thresholded brain maps of imaging cross-loadings. As the CCA was carried out on ROI-based SRN functional connectivity values, maps are displayed preserving this level of resolution. To ease visualisation and interpretation, separately for each mode, brain maps of imaging cross-loadings (panel a; brain regions–by–SRNs) were fed to a PCA (extracting only one single component a max variance). This resulted in b) a set of PCA coefficients (SRN fingerprint; also shown in Fig. 4c) and in c) PCA scores (brain map; also shown thresholded in Fig. 4e). d) For each CCA mode, showing the full set of behavioural cross-loadings.CC BY · PubMed Central
Extended Data Fig. 5 Univariate association testing between single SRNs and mental processes implicated in serotonin function. Related to Fig. 4. a) Significance level of permutation analysis of linear models testing the associations between single SRNs and cognitive processes implicated in serotonin function: delay discount (blue), reward decision-making (red), punishment decision making (yellow). b) Significance level of permutation analysis of linear models testing the associations between single SRNs and reported psychiatric problems linked to alterations of serotonin functioning: antisocial (blue), depression (red), anxiety (yellow). In both panel a) and b), statistical significance was assessed with 1,000 block-aware permutations, with FWE-corr for multiple comparisons. Showing -log10 FWE-corr P, corrected across SRNs, mental processes, and two tails. Note: significance levels are reported independently of the positive or negative sign of the association and no correction for multiple testing was applied between the two separate regression models displayed in panel a) and b). Dashed lines demarcate statistical thresholds. c) Brain regions from panel a) significantly associated (FWE-corr P < 0.05) between HTR1A SRN functional connectivity and delay discount ($40k). Some of these regions, for example the amygdala, are the same regions also reported in the CCA test. Together, these results show weak associations between mental processes previously implicated in serotonin function and single SRNs; as opposed to CCA results showing significant associations with admixtures of SRNs.
Extended Data Fig. 5 Univariate association testing between single SRNs and mental processes implicated in serotonin function. Related to Fig. 4. a) Significance level of permutation analysis of linear models testing the associations between single SRNs and cognitive processes implicated in serotonin function: delay discount (blue), reward decision-making (red), punishment decision making (yellow). b) Significance level of permutation analysis of linear models testing the associations between single SRNs and reported psychiatric problems linked to alterations of serotonin functioning: antisocial (blue), depression (red), anxiety (yellow). In both panel a) and b), statistical significance was assessed with 1,000 block-aware permutations, with FWE-corr for multiple comparisons. Showing -log10 FWE-corr P, corrected across SRNs, mental processes, and two tails. Note: significance levels are reported independently of the positive or negative sign of the association and no correction for multiple testing was applied between the two separate regression models displayed in panel a) and b). Dashed lines demarcate statistical thresholds. c) Brain regions from panel a) significantly associated (FWE-corr P < 0.05) between HTR1A SRN functional connectivity and delay discount ($40k). Some of these regions, for example the amygdala, are the same regions also reported in the CCA test. Together, these results show weak associations between mental processes previously implicated in serotonin function and single SRNs; as opposed to CCA results showing significant associations with admixtures of SRNs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Research works printed but not linked: 1

  1. Muller, C. P. & Jacobs, B. Handbook of the Behavioral Neurobiology of Serotonin (Academic Press, 2009).

Cited by

See all 108

Metadata

Authors
Salvan, P., Fonseca, M., Winkler, A. M., Beauchamp, A., Lerch, J. P., & Johansen-Berg, H.
Affiliations
  • University of Oxford (GB)
  • National Institutes of Health (US)
  • University of Toronto (CA)
Corresponding author
Salvan, Piergiorgio
Venue
Nature Neuroscience
Published
2022-12-15
Volume
26
Issue
1
Pages
53-63
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W4311664787
Cited by
101
References
88
Citations by year
2026: 24 · 2025: 36 · 2024: 30 · 2023: 10 · 2022: 1
FWCI
8.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Neuroscience (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (203139/Z/16/Z, 110027/Z/15/Z)
  • U.S. Department of Health & Human Services | National Institutes of Health (ZIA-MH002781, ZIA-MH002782)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
serotonin receptors, dorsal raphe nucleus, neuromodulation, impulsivity, negative bias, resting-state functional connectivity
MeSH terms
Animals, Humans, Magnetic Resonance Imaging, Receptors, Serotonin, Serotonin, Mice, Neuroimaging, Dorsal Raphe Nucleus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks. https://app.cochat.ai/papers/10.1038/s41593-022-01213-3
The paper
Salvan, P., Fonseca, M., Winkler, A. M., Beauchamp, A., Lerch, J. P., & Johansen-Berg, H. (2023). Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks. Nature Neuroscience. https://doi.org/10.1038/s41593-022-01213-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.